In an invited meeting review, Interpreta Vice President of Clinical Informatics and Genomics, Dr. Benjamin Yu, reports on the industry landscape and positions of governmental, academic, professional, patient advocacy and manufacturing groups on clinical regulation of next generation sequencing (NGS). The meeting which took place in February was sponsored by the FDA was public discussion… Read more »
Read technology and industry insights from Interpreta's healthcare experts.
Learn how Interpreta is helping clinicians, care managers, and health plans to orchestrate and advance quality healthcare using real-time analysis to synchronize healthcare.
Media contact: Merritt Carverinfo@interpreta.com